Related Experiment Video

Updated: May 16, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

[Maternal antibiotic use and Gram negative bacteria infection in neonates]

V Hentgen1, R Cohen

  • 1Service de Pédiatrie, Centre hospitalier de Versailles, 177, rue de Versailles, 78150 Le Chesnay, France. vhentgen@ch-versailles.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|November 27, 2012
PubMed

Insights

Maternal antibiotic use prevents early neonatal infections but may increase resistant Gram-negative bacteria. Reassessing antenatal prophylaxis strategies is crucial to balance benefits and long-term ecological impacts on newborns.

Area of Science:

  • Neonatal infections
  • Microbial resistance
  • Antibiotic stewardship

Context:

  • Maternal antibiotic use offers benefits for early neonatal group B streptococcal infections.
  • Rising resistance in Gram-negative bacteria necessitates re-evaluation of current prevention strategies.
  • The impact of antenatal antibiotic prophylaxis on the newborn microbiome requires careful consideration.

Purpose:

  • To review the current state of antenatal antibiotic prophylaxis.
  • To evaluate the bacteriological consequences of these strategies on newborns.
  • To inform evidence-based recommendations for future prevention protocols.

Summary:

  • Selective intrapartum chemoprophylaxis for early-onset group B streptococcal disease is supported despite a potential rise in resistant Gram-negative infections.
  • Other antenatal antibiotic indications are more controversial, with antibiotic choices often lacking strong methodological backing.
  • Long-term ecological effects and the use of narrow-spectrum antibiotics should guide strategies for non-GBS indications.

Impact:

  • Ensures continued protection against early-onset group B streptococcal infections.
  • Highlights the need for cautious antibiotic selection to mitigate the development of resistant Gram-negative bacteria in neonates.
  • Promotes a shift towards more targeted and ecologically sound antibiotic use in pregnancy.

More Related Videos

Probiotic Studies in Neonatal Mice Using Gavage10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

A Murine Model of Group B Streptococcus Vaginal Colonization10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...